Starling Medical has developed an innovative at-home monitoring technology called UrinDx™, which is designed to facilitate daily urine analysis for users. This FDA-registered medical device aids in the screening of urinary tract infections (UTIs) by detecting the presence of nitrites in urine, a common indicator of infection. The device is seamlessly integrated into the user's bathroom routine, sending health data to a dedicated care team for daily review. Users can access their health insights and trends through the Starling app, which also allows for on-demand clinical care and communication with healthcare providers. This proactive approach to health monitoring empowers users to take control of their urinary health while promoting good antibiotic stewardship.

In addition to the UrinDx device, Starling Medical emphasizes a comprehensive care model that includes a dedicated care team and health algorithms for early intervention. The program is designed to reduce the need for repeat clinic visits by enabling healthcare providers to offer better preventative care without impacting their bottom line. By partnering with insurance providers, Starling Medical ensures that most patients can access UrinDx at little to no upfront cost, making it an accessible option for ongoing health management. The combination of real-time insights, user-friendly technology, and a supportive care team positions Starling Medical as a leader in preventative healthcare solutions.

United States

At Starling is building a first-of-its-kind at home urology remote patient monitoring platform that seamlessly integrates into anyone's bathroom routine.

By monitoring changes in urine over time, we aim to bring the hospitalization reduction benefits of remote monitoring to a new range of chronic conditions such as recurrent UTIs, BPH, and chronic kidney disease.


Starling Medical

Company Details